| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |